Related Experiment Video
Updated: Apr 16, 2026
11:03
Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.9K
Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study
Ching-Piao Tsai1, Feng-Cheng Lin, Johnny Kuang-Wu Lee
1Neurology, Neurological Institute, Taipei Veterans General Hospital and National Yang-Ming University.
Journal of Epidemiology
|February 28, 2015
Summary
Aspirin use may reduce the risk of developing amyotrophic lateral sclerosis (ALS). This protective effect appears more significant in individuals over 55 years old, suggesting a potential preventative strategy.
Area of Science:
- Neurology
- Epidemiology
- Pharmacology
Background:
- The relationship between aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and amyotrophic lateral sclerosis (ALS) risk is not well-established.
- This study investigated the association between individual compound use and ALS risk.
Purpose of the Study:
- To determine if specific drug compounds are associated with a reduced risk of amyotrophic lateral sclerosis (ALS).
- To explore the potential neuroprotective effects of common medications.
Main Methods:
- A population-based case-control study in Taiwan involving 729 ALS patients and 7290 matched controls.
- Analysis of drug use data using conditional logistic regression, with False Discovery Rate (FDR)-adjusted P values.
Main Results:
- Aspirin, diphenhydramine, and mefenamic acid were associated with ALS risk after controlling for steroid use.
- Aspirin demonstrated an independent inverse association with ALS risk, particularly in patients over 55 years old.
Conclusions:
- Aspirin use may be associated with a reduced risk of developing amyotrophic lateral sclerosis (ALS).
- The potential benefit of aspirin in mitigating ALS risk may be more pronounced in older individuals.
